|
|
|
|
PATENTS
Novinium employees have conceived and developed virtually all of the
commercially significant cable rejuvenation technology used around the world over the last 22 years.
Since late 2002 when the early seeds of Novinium were planted, these same inventors have been continually
advancing the state-of-the-art – Safer … Faster … Better. The advanced technologies practiced by Novinium,
its partners, and its licensees are Novinium’s exclusive intellectual property and are protected by
at least 10 granted or pending patents including, but not limited to, the following published patents,
published patent applications, or unpublished applications and the foreign equivalents thereof:
- Ultrinium™ sustained pressure injection method (patent pending: US2005 0189130 A1)
- Ultrinium™ formulation optimization injection method (patent pending: US2005 0192708 A1)
- Injection Adaptor (U.S. Patent 7,195,504 and 7,538,274)
- Perfectium™ single visit, single switch injection (U.S. Patent 7,353,601)
- Formulation of Ultrinium™ & Perficio™ components (published applications: US20080223498 and US20080173467)
- Predicting performance of Electrical Power cables (published application US 2007 0046668)
- N-Rex™ submarine cable injection process (patent pending)
- N-Ter™ injection or Novinium thermally enhanced rejuvenation (patent pending)
Copies of the published documents cited above are available from the U.S. Patent and Trademark office.
The Novinium commitment to R&D continues and new patented technology will be rolled out as those novel
advances are reduced to practice. For inquiries regarding licensing Novinium technology, send your contact
information and the nature of your request to ip@novinium.com.
|
|
|
|
|